Shingles Vaccine Global Market Report 2026

Description

Shingles vaccine is a preventive immunization aimed at protecting against shingles (herpes zoster), a painful skin condition caused by the reactivation of the varicella-zoster virus. It stimulates the immune system to recognize and combat the virus, reducing the risk of developing shingles and its related complications.

The main types of shingles vaccines are live attenuated vaccines, recombinant vaccines, and subunit vaccines. A live attenuated vaccine contains a weakened form of the live pathogen that can replicate without causing disease, eliciting a strong and lasting immune response. Product examples include Shingrix, Zostavax, and SkyZoster, primarily administered to individuals aged 50-59 years, 60-69 years, and 70 years and above. These vaccines are distributed through hospital pharmacies, online pharmacies, and retail pharmacies, serving end users such as hospitals, clinics, and pharmacies.

Tariffs have influenced the shingles vaccine market by increasing costs of imported vaccines, vaccine components, and cold chain logistics equipment. Segments like recombinant and subunit vaccines are most affected, particularly in regions like North America and Europe where import dependency is high. This has led to higher vaccine costs and potential supply delays. On the positive side, tariffs have encouraged local vaccine production, innovation in cold chain and distribution solutions, and improved domestic availability of shingles vaccines.

The shingles vaccine market research report is one of a series of new reports from The Business Research Company that provides shingles vaccine market statistics, including shingles vaccine industry global market size, regional shares, competitors with a shingles vaccine market share, detailed shingles vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the shingles vaccine industry. This shingles vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The shingles vaccine market size has grown rapidly in recent years. It will grow from $5.55 billion in 2025 to $6.37 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to limited availability of shingles vaccines, reliance on live attenuated vaccines, growing elderly population, increasing incidence of herpes zoster, rising awareness of immunization benefits.

The shingles vaccine market size is expected to see rapid growth in the next few years. It will grow to $10.96 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to development of recombinant and subunit vaccines, expansion of public and private vaccination campaigns, increasing adoption of online and retail pharmacy distribution, rising government and healthcare initiatives for elderly immunization, integration of digital health monitoring for vaccination adherence. Major trends in the forecast period include rising adoption of recombinant and subunit shingles vaccines, increasing awareness of shingles prevention among older adults, expansion of vaccination programs through hospital and retail pharmacies, growth in online pharmacies and e-commerce vaccine distribution, focus on age-specific immunization strategies for 50+ population.

The expanding scope of vaccination programs is set to accelerate the shingles vaccine market ahead. Vaccination programs are structured public health efforts to deliver vaccines broadly, curbing infectious disease outbreaks. Their growth reflects heightened preventive health consciousness, spurring wider uptake to dodge illnesses. Vaccination programs boost shingles vaccine use by raising visibility and ease of access, suiting seniors and at-risk groups. They cut shingles odds and issues via prompt, broad shots, lifting community wellness. For example, in July 2025, the World Health Organization, a Switzerland-based global health body, noted first-dose human papillomavirus (HPV) vaccine coverage for girls climbed from 27% in 2023 to 31% in 2024. Thus, the rising vaccination programs are propelling the shingles vaccine market.

Leading companies in the shingles vaccine market are advancing novel formulas like recombinant adjuvanted vaccines to amplify immunity and ensure enduring shingles defense. Recombinant adjuvanted vaccines blend engineered viral elements with immune boosters for superior, prolonged shielding. For instance, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharma firm, introduced Shingrix, a shingles shot. This non-live, recombinant adjuvanted subunit vaccine goes in via two intramuscular doses for adults 50+, targeting shingles (herpes zoster) and its fallout, post-herpetic neuralgia. Boasting over 90% efficacy, it delivers robust, decade-plus protection, even for elderly or weakened immune systems.

In October 2023, GSK plc, a UK healthcare tech leader, joined forces with Chongqing Zhifei Biological Products Co. Ltd. for exclusive Shingrix distribution and promotion in China. This pact ramps Shingrix reach across 30,000+ sites while laying groundwork for co-building and selling GSK's RSV vaccine (Arexvy) to Chinese seniors. Chongqing Zhifei Biological Products Co. Ltd. is a China biotech expert in crafting, making, and spreading cutting-edge vaccines.

Major companies operating in the shingles vaccine market are Merck & Co. Inc., GSK plc, SK bioscience, Pfizer Inc, GeneOne Life Science, Curevo Inc, Novavax Inc

North America was the largest region in the shingles vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingles vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the shingles vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The shingles vaccine market consists of sales of vaccine kits, cold chain storage equipment, pre-filled syringes, vaccine delivery devices, and temperature monitoring systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Shingles Vaccine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses shingles vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for shingles vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The shingles vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Vaccine Type: Live Attenuated Vaccine; Recombinant Vaccine; Subunit Vaccine
2) By Product: Shingrix; Zostavax; Skyzoster
3) By Age Group: 50-59 Years; 60-69 Years; 70 Years And Above
4) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
5) By End User: Hospitals; Clinics; Pharmacies
Subsegments:
1) By Live Attenuated Vaccine: Virus Strain A; Virus Strain B; Virus Strain C
2) By Recombinant Vaccine: Recombinant Protein Vaccine; Recombinant Vector Vaccine; Recombinant Deoxyribonucleic Acid Vaccine
3) By Subunit Vaccine: Protein Subunit Vaccine; Conjugate Subunit Vaccine
Companies Mentioned: Merck & Co. Inc.; GSK plc; SK bioscience; Pfizer Inc; GeneOne Life Science; Curevo Inc; Novavax Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH6MSVAC02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Shingles Vaccine Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Shingles Vaccine Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Shingles Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Shingles Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Artificial Intelligence & Autonomous Intelligence
- 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Rising Adoption Of Recombinant And Subunit Shingles Vaccines
- 4.2.2 Increasing Awareness Of Shingles Prevention Among Older Adults
- 4.2.3 Expansion Of Vaccination Programs Through Hospital And Retail Pharmacies
- 4.2.4 Growth In Online Pharmacies And E-Commerce Vaccine Distribution
- 4.2.5 Focus On Age-Specific Immunization Strategies For 50+ Population

5. Shingles Vaccine Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Clinics
5.3 Pharmacies
5.4 Online Pharmacies
5.5 Elderly Care Centers

6. Shingles Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Shingles Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Shingles Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Shingles Vaccine Market Size, Comparisons And Growth Rate Analysis
7.3. Global Shingles Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Shingles Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Shingles Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Shingles Vaccine Market Segmentation

9.1. Global Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine
9.2. Global Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Shingrix, Zostavax, Skyzoster
9.3. Global Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
50-59 Years, 60-69 Years, 70 Years And Above
9.4. Global Shingles Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
9.5. Global Shingles Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Pharmacies
9.6. Global Shingles Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Virus Strain A, Virus Strain B, Virus Strain C
9.7. Global Shingles Vaccine Market, Sub-Segmentation Of Recombinant Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Recombinant Protein Vaccine, Recombinant Vector Vaccine, Recombinant Deoxyribonucleic Acid Vaccine
9.8. Global Shingles Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Protein Subunit Vaccine, Conjugate Subunit Vaccine

10. Shingles Vaccine Market Regional And Country Analysis

10.1. Global Shingles Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Shingles Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Shingles Vaccine Market

11.1. Asia-Pacific Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Shingles Vaccine Market

12.1. China Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Shingles Vaccine Market

13.1. India Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Shingles Vaccine Market

14.1. Japan Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Shingles Vaccine Market

15.1. Australia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Shingles Vaccine Market

16.1. Indonesia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Shingles Vaccine Market

17.1. South Korea Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Shingles Vaccine Market

18.1. Taiwan Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Shingles Vaccine Market

19.1. South East Asia Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Shingles Vaccine Market

20.1. Western Europe Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Shingles Vaccine Market

21.1. UK Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Shingles Vaccine Market

22.1. Germany Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Shingles Vaccine Market

23.1. France Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Shingles Vaccine Market

24.1. Italy Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Shingles Vaccine Market

25.1. Spain Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Shingles Vaccine Market

26.1. Eastern Europe Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Shingles Vaccine Market

27.1. Russia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Shingles Vaccine Market

28.1. North America Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Shingles Vaccine Market

29.1. USA Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Shingles Vaccine Market

30.1. Canada Shingles Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Shingles Vaccine Market

31.1. South America Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Shingles Vaccine Market

32.1. Brazil Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Shingles Vaccine Market

33.1. Middle East Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Shingles Vaccine Market

34.1. Africa Shingles Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Shingles Vaccine Market Regulatory and Investment Landscape

36. Shingles Vaccine Market Competitive Landscape And Company Profiles

36.1. Shingles Vaccine Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Shingles Vaccine Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Shingles Vaccine Market Company Profiles
- 36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. GSK plc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. SK bioscience Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. GeneOne Life Science Overview, Products and Services, Strategy and Financial Analysis

37. Shingles Vaccine Market Other Major And Innovative Companies

Curevo Inc, Novavax Inc

38. Global Shingles Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Shingles Vaccine Market

40. Shingles Vaccine Market High Potential Countries, Segments and Strategies

40.1 Shingles Vaccine Market In 2030 - Countries Offering Most New Opportunities
40.2 Shingles Vaccine Market In 2030 - Segments Offering Most New Opportunities
40.3 Shingles Vaccine Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer